miRNAs in Cardiovascular Biology

MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression through inhibition of protein translation or by degradation of specific transcripts. miRNAs can regulate cardiovascular health, and be potential biomarkers or targets in cardiovascular disease. Discover the latest research on miRNAs in Cardiovascular Biology here.

July 23, 2020
Open Access

Regulatory Cross Talk Between SARS-CoV-2 Receptor Binding and Replication Machinery in the Human Host

Frontiers in Physiology
Shiek S S J AhmedV Ramakrishnan
July 8, 2020
Open Access

Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights

International Journal of Molecular Sciences
Unai Galicia-GarciaCésar Martín
July 11, 2020
Open Access

Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting

International Journal of Molecular Sciences
Ali Hosseini Rad Sm, Alexander D McLellan
July 1, 2020

The roles of epicardial adipose tissue in heart failure

Heart Failure Reviews
Ying SongGang Li
July 30, 2020

MiRNAs profile as biomarkers of nutritional therapy for the prevention of type 2 diabetes mellitus: From the CORDIOPREV study

Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition
Rosa Jimenez-LucenaJose Lopez-Miranda
June 24, 2020

The role of molecular mechanism of Ten-Eleven Translocation2 (TET2) family proteins in pathogenesis of cardiovascular diseases (CVDs)

Molecular Biology Reports
Fatemeh Javaherforoosh ZadehHadi Rezaeeyan
June 17, 2020

Cardiomyocyte microvesicles: proinflammatory mediators after myocardial ischemia?

Journal of Thrombosis and Thrombolysis
Patrick Malcolm SiegelPhilipp Diehl
July 14, 2020

MicroRNA-101a protects against the H2 O2 -induced injury on cardiomyocytes via targeting BCL2L11

American Journal of Translational Research
Changlin ZhaiGang Qian
June 20, 2020

Epigenetic control of natriuretic peptides: implications for health and disease

Cellular and Molecular Life Sciences : CMLS
Speranza RubattuMaurizio Forte
June 17, 2020
Open Access

TRIF/miR-34a mediates aldosterone-induced cardiac inflammation and remodeling

Clinical Science
Shaojun LiShufeng Li
June 18, 2020
Open Access

Differential Expression and Bioinformatics Analysis of CircRNA in PDGF-BB-Induced Vascular Smooth Muscle Cells

Frontiers in Genetics
Jiangtian TianJinwei Tian
August 1, 2020
Open Access

Small Things Matter: Relevance of MicroRNAs in Cardiovascular Disease

Frontiers in Physiology
Linsey J F PetersDonato Santovito
June 21, 2020
Open Access

Impact of Phenol-Enriched Virgin Olive Oils on the Postprandial Levels of Circulating microRNAs Related to Cardiovascular Disease

Molecular Nutrition & Food Research
Lidia DaimielJosé M Ordovás

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

© 2020 Meta ULC. All rights reserved